Lipoprotein Management in Patients With Cardiometabolic Risk-Reference-Cited by-同舟云学术

Lipoprotein Management in Patients With Cardiometabolic Risk

Published:2008-04-01 Issue:4 Volume:31 Page:811-822
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Brunzell John D.¹,Davidson Michael²,Furberg Curt D.³,Goldberg Ronald B.⁴,Howard Barbara V.⁵,Stein James H.⁶,Witztum Joseph L.⁷

Affiliation:

1. Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, and the Northwest Lipid Laboratory, University of Washington, Seattle, Washington

2. University of Chicago Pritzker School of Medicine, Chicago, Illinois

3. Department of Public Health Sciences, Wake Forest University, Winston-Salem, North Carolina

4. Division of Endocrinology, Department of Medicine, University of Miami, Miami, Florida

5. MedStar Research Institute, Hyattsville, Maryland

6. Cardiovascular Medicine Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

7. Department of Medicine, University of California, San Diego, La Jolla, California

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/31/4/811/599054/zdc00408000811.pdf

Reference93 articles.

1. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal. Diabetes Care 28: 2289–2304, 2005

2. Carr MC, Brunzell JD: Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocriol Metab 6:2601–2607, 2004

3. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH: Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354:1264–1272, 2006

4. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 232:34–47, 1986

5. O'Keefe JH, Cordain L, Harris WH, Moe RM, Vogel R: Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. J Am Coll Cardiol 43:2142–2146, 2004

Cited by 475 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Beneficial Role of Caffeic Acid on Cardiovascular Complication Associated with Type-1 Diabetes Mellitus in Rats;Pharmaceutical Chemistry Journal;2024-09-14

2. The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the Diabetic Center of King Salman Bin Abdulaziz Hospital, Saudi Arabia;Cureus;2024-07-27

3. Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice;Circulation;2024-07-02

4. Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial;Arthritis Research & Therapy;2024-06-24

5. Generalized Synchronization of Different Chaotic System via Linear Mapping;International Journal of Advanced Research in Science, Communication and Technology;2024-06-08